SCHEMBL27985669

SCHEMBL27985669

CC(C)(CC(N)=O)c1cccc(O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 8/20 0.43
PARP1 P09874 1/20 0.43
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA14 Q9ULX7 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
NLRP3 Q96P20 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16771841 0.84 ACHE (0.47) ALDH1A1MAPTKMT2ACYP2C19HIF1A
SCHEMBL16081706 0.81 PARP1 (0.44) KIF11PARP1CA1CA2CA9
SCHEMBL2498564 0.80 CYP3A4 (0.41) KIF11HSD17B1HSD17B2ALDH1A1CYP3A4
SCHEMBL2813766 0.80 MAPT (0.55) KIF11ALDH1A1CYP3A4MAPTKMT2A
SCHEMBL3978037 0.78 TAAR1 (0.57) KIF11HSD17B1HSD17B2ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL5789392 0.78 MAPT (0.53) KIF11ALDH1A1CYP3A4MAPTKMT2A
SCHEMBL17700298 0.78 POLB (0.44) HSD17B1HSD17B2ALDH1A1CYP3A4CA12
Hydrochloric Acid SCHEMBL5800348 0.77 TAAR1 (0.55) KIF11HSD17B1HSD17B2ALDH1A1CYP3A4
SCHEMBL27640014 0.77 MAPT (0.62) KIF11PARP1HSD17B1HSD17B2ALDH1A1
SCHEMBL31215161 0.76 LMNA (0.44) KIF11HSD17B1HSD17B2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104244944-A Compounds for treating spinal muscular atrophy PTC THERAPEUTICS INC 2014-12-24 CN disclosed